Serviços Personalizados
Journal
Artigo
Inglês (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO 
Acessos
Links relacionados
Citado por Google 
Similares em
SciELO 
Similares em Google
Compartilhar
Permalink
Revista Colombiana de Reumatología
versão impressa ISSN 0121-8123
Resumo
GUERRERO, Andrea Cevallos et al. Treatment adherence in patients with diffuse neuropsychiatrie disorders associated with systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2022, vol.29, n.1, pp.26-30. Epub 12-Jan-2023. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2020.12.003.
Introduction:
Systemic lupus erythematosus (SLE) is a chronic disease that affects multiple systems and may include neurological and psychiatric events that could compromise treatment adherence and long-term outcomes in SLE.
Objective:
To evaluate treatment adherence in patients with diffuse neuropsychiatric disorders associated with SLE.
Methods:
A cross-sectional descriptive study was conducted. Treatment adherence was eval uated with the Morisky Medication Adherence Scale (MMAS-8) in patients with diffuse neuropsychiatric disorders associated with SLE (cognitive impairment, psychosis, mood disorders, and anxiety).
Results:
A total of 60 patients with neuropsychiatric disorders associated with SLE were included. Thirteen patients (21.6%) had high adherence, 9 (15%) had medium adherence, and 38 patients (63.3%) had low treatment adherence.
Conclusion:
This study has identified that almost two-thirds of the participants (63.3%) had low treatment adherence.
Palavras-chave : Neuropsychiatry; Lupus; Adherence; Anxiety; Depression; Ecuador.
